Tuberculosis, caused by Mycobacterium (M.)
tuberculosis, is a devastating
infectious disease causing many deaths worldwide. Non-specific host defense mechanisms such as the coagulation and fibrinolytic system may give insight in possible new therapeutic targets.
Plasminogen activator inhibitor type-1 (PAI-1), an important regulator of
inflammation and fibrinolysis, might be of interest as
tuberculosis patients have elevated plasma levels of
PAI-1. In this study we set out to investigate the role of
PAI-1 during
tuberculosis in vivo. Wildtype (WT) and
PAI-1 deficient (PAI-1⁻/⁻) mice were intranasally infected with M.
tuberculosis H37rv and sacrificed after 2, 5 and 29 weeks. Five weeks post-
infection, bacterial loads in lungs of PAI-1⁻/⁻ mice were significantly higher compared to WT mice, while no differences were seen 2 and 29 weeks post-
infection. At two weeks post-
infection increased influx of macrophages and lymphocytes was observed.
PAI-1 deficiency was associated with a reduced
cytokine response in the lungs; however, upon stimulation with
tuberculin purified
protein derivative (
PPD), PAI-1⁻/⁻ splenocytes released increased levels of IFN-γ compared to WT. No clear differences were found between PAI-1⁻/⁻ and WT mice at 29 weeks after
infection. In conclusion, these data suggest that
PAI-1 contributes to transient, non-specific changes in immunity during the early phase of murine
tuberculosis.